Delcath SystemsDCTH +5.12%70 Quick Ratio is 10.33 as of Mar. 2026, which is 683% above its 10-year median of 1.32. GuruFocus rates DCTH with a GF Score™ of 70/100 and a GF Value™ of $36.72 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Delcath Systems ranks better than 95.32% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Delcath Systems's quick ratio for the quarter that ended in Mar. 2026 was 10.33.
Delcath Systems has a quick ratio of 10.33. It generally indicates good short-term financial strength.
The historical rank and industry rank for Delcath Systems's Quick Ratio or its related term are showing as below:
DCTH'
s Quick Ratio Range Over the Past 10 Years
Min: 0.07 Med: 1.32 Max: 14.61
Current: 10.33
During the past 13 years, Delcath Systems's highest Quick Ratio was 14.61. The lowest was 0.07. And the median was 1.32.
DCTH's Quick Ratio is ranked better than 95.32% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.865
vs DCTH: 10.33
Delcath Systems (NAS:DCTH) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Delcath Systems Quick Ratio Related Terms
Delcath Systems Quick Ratio Historical Data
* Premium members only.
The historical data trend for Delcath Systems's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Delcath Systems's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Delcath Systems Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Delcath Systems's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Delcath Systems's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Delcath Systems's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Delcath Systems (DCTH) has a Quick Ratio of 10.33 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Delcath Systems and its competitors. This is 683% above median its historical median of 1.32. Over the past decade, Delcath Systems' Quick Ratio has ranged from 0.07 to 14.61. According to the industry distribution chart, Delcath Systems ranks #40 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 4.7%.
Is Delcath Systems' Quick Ratio too high?
Delcath Systems' current Quick Ratio of 10.33 is 683% above median its 10-year median of 1.32. Over the past 10 years, this metric has ranged from a low of 0.07 to a high of 14.61. The Medical Devices & Instruments industry median Quick Ratio is 1.87. Delcath Systems' value of 10.33 is 453.9% above this industry median. Based on the distribution chart, Delcath Systems ranks #40 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Delcath Systems has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Delcath Systems' Quick Ratio compare to OFIX and VMD?
According to the Medical Devices & Instruments industry distribution chart, Delcath Systems ranks #40 out of 854 companies for Quick Ratio. This places Delcath Systems in the top 5% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.87. Delcath Systems' value of 10.33 is 453.9% above this benchmark. Historically, Delcath Systems' own Quick Ratio has ranged from 0.07 to 14.61 over the past decade. While the company's 10-year median is 1.32 vs. the industry median of 1.87, Delcath Systems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.87, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Delcath Systems's current Quick Ratio of 10.33 is 453.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Delcath Systems and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Delcath Systems's current Quick Ratio is 10.33, which is 683% above median its own 10-year median of 1.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delcath Systems stock overvalued right now?
Based on GuruFocus' analysis, Delcath Systems (DCTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $36.72, compared to a current price of $12.94 — trading 64.8% below its estimated fair value. The current Quick Ratio is 10.33, which is 683% above median its 10-year median of 1.32 and 453.9% above the Medical Devices & Instruments industry median of 1.87. Delcath Systems' overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Delcath Systems (DCTH), the current Quick Ratio is 10.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Delcath Systems (DCTH) Overvalued in 2026?
Based on GuruFocus' analysis, Delcath Systems stock appears to be undervalued.
The current stock price of $12.94 is trading 64.8% below its estimated GF Value™ of $36.72.
GuruFocus considers Delcath Systems to be Significantly Undervalued.
Key valuation signals for DCTH:
Quick Ratio: 10.33 (683% above median its 10-year median of 1.32)
GF Value™: $36.72 vs. price of $12.94 (64.8% below fair value)
Industry Position: 453.9% above the Medical Devices & Instruments median (#40 of 854)
No single metric tells the full story. See the DCTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
70GF Score
Get the complete analysis for DCTH
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DCTH has been successfully added to your 
